Bearish flow noted in Bristol Myers (BMY) Squibb with 8,148 puts trading, or 1.1x expected. Most active are Aug-25 52.5 puts and 7/11 weekly 49 calls, with total volume in those strikes near 4,800 contracts. The Put/Call Ratio is 2.25, while ATM IV is up nearly 3 points on the day. Earnings are expected on July 31st.
Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on BMY:
- Bristol-Myers Squibb’s Promising SLE Study: A Potential Game-Changer?
- Bristol-Myers Squibb’s Ozanimod Study: A Potential Game-Changer for Ulcerative Colitis Treatment
- Pfizer and Bristol-Myers Squibb’s Promising Study on Multiple Myeloma Treatment
- Bristol-Myers Squibb’s MORAb-202 Study: A Potential Game-Changer in Cancer Treatment
- Bristol-Myers Squibb’s Promising Phase 3 Study for Pulmonary Fibrosis
